SE9202318L - Nya peptider, diagnostiska antigen, användning därav, vacciner och medikamenter - Google Patents

Nya peptider, diagnostiska antigen, användning därav, vacciner och medikamenter

Info

Publication number
SE9202318L
SE9202318L SE9202318A SE9202318A SE9202318L SE 9202318 L SE9202318 L SE 9202318L SE 9202318 A SE9202318 A SE 9202318A SE 9202318 A SE9202318 A SE 9202318A SE 9202318 L SE9202318 L SE 9202318L
Authority
SE
Sweden
Prior art keywords
peptides
vaccines
drugs
diagnostic antigens
medicaments
Prior art date
Application number
SE9202318A
Other languages
English (en)
Other versions
SE9202318D0 (sv
Inventor
J Blomberg
R Pipkorn
M Lindeskog
Original Assignee
Replico Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Replico Medical Ab filed Critical Replico Medical Ab
Priority to SE9202318A priority Critical patent/SE9202318L/sv
Publication of SE9202318D0 publication Critical patent/SE9202318D0/sv
Priority to PCT/SE1993/000671 priority patent/WO1994003493A1/en
Priority to AU47670/93A priority patent/AU4767093A/en
Publication of SE9202318L publication Critical patent/SE9202318L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9202318A 1992-08-10 1992-08-10 Nya peptider, diagnostiska antigen, användning därav, vacciner och medikamenter SE9202318L (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9202318A SE9202318L (sv) 1992-08-10 1992-08-10 Nya peptider, diagnostiska antigen, användning därav, vacciner och medikamenter
PCT/SE1993/000671 WO1994003493A1 (en) 1992-08-10 1993-08-08 Peptides derived from an immunosuppressive region in the retroviral genome
AU47670/93A AU4767093A (en) 1992-08-10 1993-08-08 Peptides derived from an immunosuppressive region in the retroviral genome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9202318A SE9202318L (sv) 1992-08-10 1992-08-10 Nya peptider, diagnostiska antigen, användning därav, vacciner och medikamenter

Publications (2)

Publication Number Publication Date
SE9202318D0 SE9202318D0 (sv) 1992-08-10
SE9202318L true SE9202318L (sv) 1994-02-11

Family

ID=20386905

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9202318A SE9202318L (sv) 1992-08-10 1992-08-10 Nya peptider, diagnostiska antigen, användning därav, vacciner och medikamenter

Country Status (3)

Country Link
AU (1) AU4767093A (sv)
SE (1) SE9202318L (sv)
WO (1) WO1994003493A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511277A (ja) * 1998-04-08 2002-04-16 エムエス・リサーチ・アクティーゼルスカブ 多発性硬化症および他の脱髄性疾患の診断

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4794168A (en) * 1984-04-24 1988-12-27 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
US4833071A (en) * 1987-01-09 1989-05-23 United Biomedical, Inc. Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor
AU1366088A (en) * 1987-01-28 1988-08-24 Ortho Pharmaceutical Corporation Immunosuppressive peptides and methods of use
US5017687A (en) * 1988-03-10 1991-05-21 Virovahl, S.A. Peptides for the detection of HTLV-1 infection
SE8900721D0 (sv) * 1989-03-02 1989-03-02 Blomberg Jonas Methods for detection of antibodies to
JP2807287B2 (ja) * 1989-10-13 1998-10-08 株式会社医学生物学研究所 ペプチドおよびその用途

Also Published As

Publication number Publication date
WO1994003493A1 (en) 1994-02-17
AU4767093A (en) 1994-03-03
SE9202318D0 (sv) 1992-08-10

Similar Documents

Publication Publication Date Title
RU2432364C2 (ru) ПОЛИКЛОНАЛЬНОЕ АНТИТЕЛО ПРОТИВ Nogo, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ПРИМЕНЕНИЕ АНТИТЕЛА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА
NO20002413D0 (no) Antistoffer mot Moraxella proteiner og anvendelse derav, samt sett for pÕvisning av antigen og farmasøytisk preparat som inneholder antistoffer
WO1996029605A3 (en) Compounds and methods for the dectection of t. cruzi infection
DK0523395T3 (da) Seroreaktive områder på proteinerne E1 og E2 i HPV 16
EP0284587A3 (en) Synthetic peptide antigens for the detection of hiv-1 infection
ATE132197T1 (de) Monoklonale antikörper
EE03287B1 (et) T-raku antigeeni retseptori V-piirkonna proteiinid, nende valmistamismeetodid, nende saamiseks vajalik ekspressioonivektor ning bakteriaalne rakk, neid sisaldav farmatseutiline kompositsioon, nende kasutamine medikamentide tootmisel ning diagnoosimee
DK0661999T3 (da) Vacciner mod felint immundefekt virus (FIV)
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
ATE122394T1 (de) Pankreatische isletzellen-antigene, erhalten durch molekulare klonierung.
BR9106159A (pt) Polipeptideo sintetico,vacina,estojo para detectar hiv ou anticorpos contra hiv,molecula de dna,composicao farmaceutica,anticorpo ou fragmento de ligacao de antigeno do mesmo,processos de terapia ou profilaxia de infeccao hiv,de detectar hiv,de diagnosticar infeccao hiv e para a manufatura de um polipeptideo sintetico,de uma composicao farmaceutica e de um anticorpo ou fragmento de ligacao do mesmo
SE9202968L (sv) Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter
Jarrett et al. Antibody response and virus survival in cats vaccinated against feline leukaemia
ES2087111T3 (es) Vacuna sintetica para la induccion especifica de linfocitos t citotoxicos.
DE3782771D1 (de) Gegen pseudomonas aeruginosa infektionen wirksame praeparationen und verfahren zu ihrer herstellung.
ATE94880T1 (de) Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung.
Wimperis et al. B cell development and regulation after T cell-depleted marrow transplantation.
ATE375514T1 (de) Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion
JPS6463392A (en) Monoclonal antibody against specific antigen for human immunodeficiency virus
SE9202318L (sv) Nya peptider, diagnostiska antigen, användning därav, vacciner och medikamenter
Geczy et al. Antibodies to Guinea Pig Lymphokines: IV. Suppression of the Mixed Leukocyte Culture Reaction by anti-Lymphokine Globulin
RU94040393A (ru) Синтетические пептиды для вакцины против краснухи
EP0293827A3 (en) Assay for leishmaniasis
DE69311796D1 (de) Peptide von dem caseinomacropeptid, antikorper dagegen und ihre andwendungen
FR2694938B1 (fr) Nouveaux peptides, anticorps diriges contre ces peptides, anticorps anti-idiotypiques, application a titre de medicaments, compositions pharmaceutiques et kits de diagnostic les renfermant.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9202318-3